WASHINGTON--In the January issue of Clinical Biochemistry, scientists and physicians with the Physicians Committee for Responsible Medicine (PCRM) outline the method used to develop a cruelty-free ELISA for human insulin that uses monoclonal antibodies produced by cells cultured in an animal-serum-free medium. PCRM’s insulin ELISA, the first of its kind, provides precision and reliability equal to methods currently used in clinical research. PCRM’s insulin ELISA is now commercially available for research purposes from Millipore of St. Charles, Mo., which reports that it is selling briskly. The new ELISA also serves as a guide for the development of serum-free immunoassays for other hormones and bio-markers. >>> Discuss This Story
